Showing results (1-10 of 20) with videos related to

Sort By:
Pageof 2
Cancer Cell|October 30, 2020
The Challenges of Tumor Mutational Burden as an Immunotherapy BiomarkerDenis L Jardim, Aaron Goodman, Debora de Melo Gagliato, et al.
Biodrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy|September 2, 2020
Immunotherapy in Breast Cancer: Current Practice and Clinical ChallengesDebora de Melo Gagliato, Antonio C Buzaid, Jose Perez-Garcia, et al.
Cancers|September 5, 2020
CDK4/6 Inhibitors in Hormone Receptor-Positive Metastatic Breast Cancer: Current Practice and KnowledgeDebora de Melo Gagliato, Antonio C Buzaid, Jose Manuel Perez-Garcia, et al.
Oncotarget|January 30, 2016
Mechanisms of resistance and sensitivity to anti-HER2 therapies in HER2+ breast cancerDebora de Melo Gagliato, Denis Leonardo Fontes Jardim, Mario Sergio Pereira Marchesi, et al.
Biochimica Et Biophysica Acta. Reviews on Cancer|October 25, 2017
Tumor-infiltrating lymphocytes in Breast Cancer and implications for clinical practiceDebora de Melo Gagliato, Javier Cortes, Giuseppe Curigliano, et al.
The Oncologist|May 21, 2020
Impact of Delayed Neoadjuvant Systemic Chemotherapy on Overall Survival Among Patients with Breast CancerDebora de Melo Gagliato, Xiudong Lei, Sharon H Giordano, et al.
Journal of Medical Case Reports|March 15, 2016
An uncommon response to metronomic therapy in a heavily pretreated patient with metastatic carcinosarcoma: a case reportDebora de Melo Gagliato, Rudinei Diogo Marques Linck, Regis Otaviano Franca Bezerra, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 29, 2014
Clinical impact of delaying initiation of adjuvant chemotherapy in patients with breast cancerDebora de Melo Gagliato, Ana M Gonzalez-Angulo, Xiudong Lei, et al.
Breast Care (Basel, Switzerland)|November 19, 2014
Cardiac safety of (neo)adjuvant trastuzumab in the community setting: a single-center experienceLeonardo Gomes da Fonseca, Debora de Melo Gagliato, Tiago K Takahashi, et al.
Plos One|April 8, 2016
The Association between EGFR and cMET Expression and Phosphorylation and Its Prognostic Implication in Patients with Breast CancerYoung Kwang Chae, Debora de Melo Gagliato, Sachin Gopalkrishna Pai, et al.
Pageof 2